Millipore
MilliporeSigma is the U.S./Canada Life Life Science arm of Merck KGaA, selling research chemicals, bioprocessing products, CDMO/testing services, and AI drug discovery platforms to pharmaceutical manufacturers, biotech firms, and academic labs globally.
- Company typePrivate
- Founded2015
- HeadquartersBillerica, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Millipore does
MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany — formed following Merck KGaA's 2015 acquisition of Sigma-Aldrich — and operates as a privately held subsidiary within the publicly listed parent (Frankfurt: MRK). Headquartered in Billerica, Massachusetts with 10,000+ employees, the company maintains a multi-brand architecture spanning Millipore® (biopharma products and CTDMO services), Sigma-Aldrich® (lab and production materials), SAFC® (raw material solutions), Supelco® (analytical products), Milli-Q® (lab water), and BioReliance® (contract testing), serving pharmaceutical manufacturers, biotech firms, academic researchers, and industrial labs across North America, Europe, and Asia Pacific.
The portfolio covers the full drug development continuum: research chemicals, reagents, filtration and water purification, cell culture media, analytical chromatography, single-use bioreactors and the Mobius ADC Reactor for antibody-drug conjugate manufacturing, the AIDDISON / SYNTHIA AI drug discovery SaaS platform, mAb and mRNA integrated development offerings, the AAW Automated Assay Workstation in partnership with Opentrons, Amsphere Protein A chromatography resins, and the Bio-Based Solvent Portfolio for HPLC. Underlying technology spans AI-powered generative molecular design and retrosynthesis planning, automated lab workflows, bio-based chemistry manufacturing, and large-scale bioprocessing.
Revenue is generated through a multi-channel model: direct e-commerce via sigmaaldrich.com for research customers (pay-as-you-go catalog sales), enterprise field sales for global pharma and biopharma accounts, CDMO/contract manufacturing services, contract testing services (BioReliance), custom synthesis, digital subscriptions for AIDDISON, and CDN distribution through CDMO partnerships such as Simtra BioPharma Solutions. Recent strategic activity includes three completed acquisitions in 2024–2026 (Mirus Bio for $600M, HUB Organoids for €104M, and JSR Life Sciences' chromatography business), partnerships with Siemens (autonomous labs/Dotmatics), Promega (organoid assays), Opentrons, imec, and Rapid Micro Biosystems, and active participation in BIO International Convention thought leadership.
Millipore firmographics
Firmographics- Name
- Millipore
- Legal name
- Merck KGaA, Darmstadt, Germany
- Website
- https://millipore.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- MilliporeSigma is the U.S./Canada Life Life Science arm of Merck KGaA, selling research chemicals, bioprocessing products, CDMO/testing services, and AI drug discovery platforms to pharmaceutical manufacturers, biotech firms, and academic labs globally.
- Ownership category
- akta.pro rank
Millipore industry classification
Industry- Product category
- Life Science Products and Biopharmaceutical Services
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Analytical Laboratory Instrument Manufacturing (334516), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
- akta.pro secondary industries
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)
Keywords
Where Millipore is headquartered
LocationHeadquarters
- HQ city
- Billerica
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Millipore business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Life Science Products: Broad portfolio of research chemicals, biochemicals, reagents, labware, filtration products, water purification systems, and analytical products sold directly through e-commerce and sales force to pharmaceutical, biotech, and academic customers
- Contract Manufacturing Services: CDMO services including process solutions, biopharmaceutical manufacturing, ADC manufacturing, chromatography, and custom manufacturing for pharma and biopharma clients
- Contract Testing Services: BioReliance contract testing services providing quality control, microbial detection, and regulatory compliance testing for pharmaceutical manufacturing
- Custom Products: Custom synthesis of DNA oligos, RNA, siRNA, custom peptides, and specialized chemical products for specific customer requirements
- Digital Solutions: Software and digital platforms including AIDDISON AI platform, cloud-based solutions for lab operations, and digital workflow tools
- ADC Manufacturing: Specialized manufacturing capabilities for antibody-drug conjugates including Mobius ADC Reactor technology and process solutions for oncology therapeutics
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | E-commerce standard pricing for research chemicals and lab supplies |
Go-to-market motion5 records
Distribution channels4 records
Marketing channels6 records
Millipore product offering
Product offeringCore offering
Millipore (operating as MilliporeSigma in the U.S. and Canada) manufactures and sells life science research chemicals, biochemicals, reagents, filtration products, lab water purification systems, chromatography resins, bioprocessing single-use equipment, and integrated digital platforms, while also providing contract development and manufacturing (CDMO/CTDMO) services, contract testing, and custom synthesis for pharmaceutical and biopharmaceutical manufacturers, academic researchers, and quality control laboratories globally. The company spans the full biopharmaceutical value chain from discovery (e.g., AIDDISON AI drug discovery) through process development, commercial manufacturing, and regulatory quality control testing.
Product overview
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, offers a broad portfolio of products for pharmaceutical development and manufacturing. The company operates a multi-brand architecture comprising Millipore® (Expert Pharma/BioPharma products and CTDMO services), Sigma-Aldrich® (Lab and production materials), SAFC® (Pharma raw material solutions), Supelco® (Analytical products), Milli-Q® (Lab water solutions), and BioReliance® (Contract testing services). Key product categories span analytical chemistry, cell culture and analysis, chemistry and biochemicals, filtration, industrial microbiology, lab automation, molecular biology, protein biology, and water purification. The company provides integrated offerings for mRNA development and manufacturing, monoclonal antibody (mAbs) development and manufacturing, and contract manufacturing/testing services. Notable recent product launches include the AIDDISON AI-powered drug discovery platform, AAW Automated Assay Workstation, Bio-Based Solvent Portfolio for HPLC, and Mobius ADC Reactor for antibody-drug conjugate manufacturing. Strategic acquisitions include JSR Life Sciences' chromatography business (Amsphere Protein A Resins) and HUB Organoids for organoid development.
Differentiator
Problem solved
Functional benefit
Brands
- Millipore®: Expert Pharma / BioPharma Products & CTDMO Services
- Sigma-Aldrich®
- SAFC®
- Supelco®
- Milli-Q®
- BioReliance®
- AIDDISON
- Mobius ADC Reactor
- DOZN
- AAW Automated Assay Workstation
Products and services
- AIDDISON Drug Discovery Platform AI-powered drug discovery SaaS platform that integrates with SYNTHIA retrosynthesis software for automated molecular design and synthesis planning. Targeted at pharmaceutical and biotechnology discovery teams.
- Mobius ADC Reactor Single-use reactor designed for antibody-drug conjugate (ADC) manufacturing to enhance efficiency and scalability in ADC production. Targeted at biopharmaceutical manufacturers producing oncology therapeutics.
- AAW Automated Assay Workstation Automated laboratory workstation for assay automation that improves efficiency and consistency in experimental workflows, developed in partnership with Opentrons Labworks. Targeted at life science research laboratories.
- Bio-Based Solvent Portfolio for HPLC First bio-based solvent portfolio for HPLC manufactured using renewable feedstocks, delivering average 25.9% lower CO2 equivalents versus fossil-fuel-based alternatives while maintaining equivalent analytical performance. Includes drop-in replacements for acetonitrile, methanol, and ethanol. Targeted at analytical laboratories seeking sustainable alternatives.
- Amsphere Protein A Resins Protein A chromatography resins for scalable purification of monoclonal antibodies and biopharmaceutical manufacturing from development through commercial scale. Acquired from JSR Life Sciences. Targeted at biopharmaceutical manufacturers producing mAbs and biologics.
- Millex Syringe Filters Syringe filters for laboratory filtration applications in analytical and preparative workflows. Targeted at life science research laboratories and analytical chemists.
- Amicon Centrifugals Centrifugal filter devices for protein concentration, desalting, and buffer exchange in sample preparation. Targeted at protein biology and biochemistry researchers.
- Millipore Filter Membranes Filter membranes for laboratory and process filtration applications across research and manufacturing. Targeted at research laboratories and bioprocessing manufacturers.
- ReCycler Solvent Systems Solvent recovery and recycling systems that deliver solvents and reagents in returnable containers, reducing packaging waste and eliminating hazardous disposal costs. Targeted at analytical laboratories seeking sustainable solvent management.
- BioReliance Contract Testing Services Quality control and regulatory compliance testing services for pharmaceutical and biopharmaceutical products, including microbial detection, sterility testing, and environmental monitoring. Targeted at pharmaceutical manufacturers requiring regulatory-grade testing.
- Contract Development and Manufacturing Services (CDMO/CTDMO) Pharmaceutical contract development, testing, and manufacturing organization (CDMO/CTDMO) services for drug substance and drug product manufacturing. Targeted at pharmaceutical and biopharmaceutical companies seeking outsourced manufacturing capacity.
- mRNA Development and Manufacturing Services Integrated solutions for mRNA-based therapeutics development and manufacturing from research through commercial scale. Targeted at pharmaceutical and biotechnology companies developing mRNA vaccines and therapeutics.
- Monoclonal Antibody (mAbs) Development and Manufacturing Services Integrated monoclonal antibody development and manufacturing services covering the full biopharmaceutical pipeline. Targeted at biopharmaceutical companies developing therapeutic antibodies.
- Digital Solutions for Life Science
Quantifiable outcome
- 25.9% lower CO2 equivalents compared to conventional fossil-fuel-based solvents
- +2 more outcomes
Companies that use Millipore
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Millipore technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature9 records
Millipore partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, flagship and minor.
- JSR Life Sciences (Acquisition)coreCompleted acquisition of JSR Life Sciences' chromatography business April 2026, adding Amsphere Protein A resins and advanced Protein A chromatography capabilities with Belgium-based team of 50+ employees.
- Rapid Micro BiosystemscoreStrategic collaboration advanced through Services Agreement execution in 2026, with established demo labs. Partnership in second year focused on Growth Direct automated microbial quality control platform for pharmaceutical manufacturing.
- SiemensflagshipMerck KGaA signed memorandum of understanding with Siemens in September 2025 to connect digital experiment design to physical lab operations, leveraging Dotmatics technology that Siemens acquired for $5.1 billion. Early pilots using Dotmatics' Luma platform to integrate digital and physical lab workflows.
- Simtra BioPharma SolutionscoreStrategic partnership established June 2025 to offer integrated ADC drug substance and drug product manufacturing through seamless coordination and shared project management, providing end-to-end services.
- NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals)minorParticipation in NIIMBL initiative developing standardized ontologies for biopharmaceutical manufacturing data interoperability, enabling effective data flow between unit operations and systems.
- PromegacorePartnership launched October 2024 to co-develop assay technologies capable of tracking cellular activity in real time within organoids that mimic human biology, aiming to advance drug screening and discovery.
- Opentrons LabworkscoreAutomation partnership to enhance laboratory workflows through the AAW Automated Assay Workstation launch, combining Opentrons automation with MilliporeSigma assay expertise.
- imeccoreStrategic partnership to expand organoid capabilities as part of next-generation biology solutions, leveraging imec's expertise in microelectronics and biosensors.
- Mirus Bio (Acquisition)coreAcquisition of Mirus Bio for $600 million in H1 2024 to strengthen gene therapy capabilities and manufacturing capacity.
- Beyond BenignflagshipMulti-million-dollar partnership expanded March 2023 to integrate green chemistry principles into higher education. Initiative surpassed 2025 target of 1.4 million students, achieving 1.6 million globally. 2030 goal: 15.5 million students and 10,000 faculty worldwide.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Millipore competitors and assessment
Company assessmentDirect peers
- Sartorius AG: German bioprocessing specialist competing in single-use bioreactors, filtration, and cell culture media—core process solutions categories for MilliporeSigma's pharma and biopharma manufacturing customers.
- Lonza Group: Global CDMO leader in biologics, cell & gene therapy, and mRNA manufacturing that directly competes for the same biopharma process solutions and contract manufacturing spend as MilliporeSigma.
- Catalent: Major CDMO for biologics, softgel, and oral dose forms that overlaps with MilliporeSigma's contract manufacturing and ADC services, including biopharma fill-finish and drug product capabilities now extended through the Simtra partnership.
- Thermo Fisher Scientific: Largest direct competitor spanning lab products and biopharma services through the Patheon CDMO acquisition. Overlaps with MilliporeSigma in research chemicals, bioprocessing, and contract manufacturing for pharma/biotech customers.
- Danaher Corporation (Cytiva): Operates Cytiva bioprocessing business (formerly GE Healthcare Life Sciences) which directly competes in upstream/downstream processing, single-use systems, and Protein A chromatography—the same downstream processing market MilliporeSigma entered via the JSR acquisition.
Emerging players
- Bio-Techne: Reagents and proteomics tools company with growing exposure to cell therapy and gene therapy workflow reagents that competes in adjacent life-science research and bioprocessing reagent categories.
Broad incumbents
- Agilent Technologies: Broad incumbent in analytical instruments, chromatography, and life science research tools that competes with Supelco and Sigma-Aldrich branded analytical products for pharma QC and research customers.
- Waters Corporation: Specialty analytical instruments and chromatography systems company competing in HPLC and mass spectrometry—directly relevant given MilliporeSigma's new bio-based HPLC solvent portfolio targets the same analytical workflow customers.
- Charles River Laboratories: Broader life sciences services company with CDMO, contract testing, and research models businesses that overlaps with BioReliance contract testing and MilliporeSigma's biologics safety testing offerings.
Others
- Eppendorf: Lab equipment and consumables manufacturer overlapping with MilliporeSigma's labware, filtration, and bioreactor consumables categories for academic and biotech research customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Millipore social profiles
Digital presenceMillipore financial estimates
Financial estimateRevenue estimate
Valuation estimate
Millipore leadership team
Management profileNumber of profiles
Profiles4 records
Millipore subsidiaries and ownership
Company hierarchySubsidiaries3 records
Millipore funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Millipore M&A and investment
M&A and investmentM&A5 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Millipore
What does Millipore do?
Millipore (operating as MilliporeSigma in the U.S. and Canada) manufactures and sells life science research chemicals, biochemicals, reagents, filtration products, lab water purification systems, chromatography resins, bioprocessing single-use equipment, and integrated digital platforms, while also providing contract development and manufacturing (CDMO/CTDMO) services, contract testing, and custom synthesis for pharmaceutical and biopharmaceutical manufacturers, academic researchers, and quality control laboratories globally. The company spans the full biopharmaceutical value chain from discovery (e.g., AIDDISON AI drug discovery) through process development, commercial manufacturing, and regulatory quality control testing.
Is Millipore a public or private company?
Millipore is a private company. It is classified as corporate owned and is currently operating.
When was Millipore founded?
Millipore was founded in 2015. It employs 5,001 to 10,000 people.
Where is Millipore based?
Millipore is headquartered in Billerica, United States, in the North America region.
How does Millipore make money?
Six revenue lines are on record. Life Science Products are the primary driver. The others are contract Manufacturing Services, contract Testing Services, custom Products, digital Solutions and ADC Manufacturing.
Who are Millipore's main competitors?
Direct peers on record are Sartorius AG, Lonza Group, Catalent, Thermo Fisher Scientific and Danaher Corporation (Cytiva). Bio-Techne is listed as an emerging player. Broad incumbents are Agilent Technologies, Waters Corporation and Charles River Laboratories. Eppendorf is listed as an others.
Does Millipore have an API?
No public API is recorded for Millipore.
What industry is Millipore in?
Millipore's product category is Life Science Products and Biopharmaceutical Services. Its primary akta.pro industry code is HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO, with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 3254 and its SIC code is 8731.